CT versus MRI planning for high-dose-rate prostate brachytherapy
Part of Cancer, Kidney & urinary clinical trials.
This trial compares two imaging methods (CT and MRI) used to plan a type of radiation therapy for prostate cancer called high-dose-rate brachytherapy. The goal is to see if one method provides better targeting of the cancer while sparing healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 18 or older.
- You have been diagnosed with prostate cancer (confirmed by biopsy).
- Your cancer has not spread to nearby lymph nodes or other parts of the body.
- You plan to receive curative treatment with high-dose-rate brachytherapy, with or without external beam radiation.
- You have not had radiation therapy to the pelvic area before.
- You have not had a prior prostate MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a targeted radiation treatment called HDR brachytherapy for prostate cancer that hasn't spread. It aims to treat only the cancer spots seen on MRI, which may reduce side effects.
This study tests a new way to give high-dose radiation to prostate cancer while using an MRI to precisely target the tumor. It is for early-stage prostate cancer, and aims to reduce side effects by treating only the cancer, not the whole prostate.
This trial tests two ways to plan radiation treatment for prostate cancer: one using a computer program (RapidPlan) and the other using human experts. The goal is to see if the computer-assisted method works as well or better.
This trial studies a combination of two radiation types—high-dose-rate brachytherapy and stereotactic body radiotherapy—to treat certain intermediate- to high-risk prostate cancers. It may help by aiming radiation closely at the prostate while also targeting the cancer from outside the body.
This study tests a targeted radiation approach called high-dose-rate (HDR) brachytherapy, guided by MRI, for certain people with recurrent or higher-risk prostate cancer. It may help deliver radiation more precisely, depending on your cancer type and prior treatments.
This study tests a precise radiation treatment for prostate cancer that uses MRI images to guide the radiation beams. It may be an option for men with higher-risk prostate cancer who can have an MRI and have not had radiation before.
Hear when a new Prostate Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.